Axolot Solutions (AXOLOT) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
2024 marked a strategic transformation, highlighted by a major partnership with Mellifiq and a record order for a large AxoPur® plant at Aspa Bruk, valued at over 80 Mkr, with Axolot's share estimated at 11 Mkr in direct revenues, mainly in 2025.
Axolot divested its subsidiary to Mellifiq, acquiring a 19% stake in Mellifiq and focusing on a capital-light, partner-driven international expansion model.
Two fully subscribed share issues raised 24.4 Mkr before costs, supporting investment in Mellifiq and international growth.
The company expects future earnings primarily from reactor sales, royalties, and dividends from partner companies.
Financial highlights
Full-year 2024 operating income was 2,980 tkr (2023: 1,652 tkr), with Q4 external revenue of 256 tkr.
Operating result for 2024 was -5,818 tkr (2023: -3,072 tkr), with Q4 at -3,470 tkr, impacted by one-time legal costs and resource transfers.
Net result for 2024 was -18,008 tkr (2023: -12,868 tkr), including a -12,250 tkr write-down of subsidiary shares.
Cash and cash equivalents at year-end were 7,282 tkr (2023: 14,866 tkr), with a negative cash flow from operations and investments of -16,374 tkr.
No dividend proposed for 2024.
Outlook and guidance
2025 revenues are expected to be driven by reactor sales and royalties, with the Aspa Bruk project and new orders in Chile and Stockholm as key growth drivers.
The company aims to establish 2–3 new international partnerships in 2025, focusing on markets with strong environmental regulation and water scarcity.
Expansion will be gradual, matching organizational capacity and market potential.
Latest events from Axolot Solutions
- Revenue surged in 2025, supported by expansion and key partnerships, despite a net loss.AXOLOT
Q4 202511 Feb 2026 - Sales and operating results improved in Q3 2025, with accelerated international expansion.AXOLOT
Q3 202528 Oct 2025 - Order growth, international expansion, and regulatory tailwinds drive positive Q2 momentum.AXOLOT
Q2 202529 Jul 2025 - Q3 sales surged, but losses deepened as Axolot completed a transformative merger with Mellifiq.AXOLOT
Q3 202413 Jun 2025 - Sales up but losses widen; new funding secured for growth amid rising market demand.AXOLOT
Q2 202413 Jun 2025 - Q1 2025 saw Axolot's sales surge and key PFAS contracts secured via partner expansion.AXOLOT
Q1 20256 Jun 2025